v3.22.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2023
Jan. 31, 2022
Jan. 31, 2021
Operating activities      
Net loss $ (182,285) $ (232,378) $ (92,629)
Adjustments to reconcile net loss to net cash provided by operating activities:      
Depreciation and amortization 77,245 55,908 38,710
Amortization of intangible assets 16,565 12,902 1,448
Amortization of deferred contract acquisition costs 170,808 113,884 66,425
Non-cash operating lease cost 9,440 9,103 7,786
Stock-based compensation expense 526,504 309,952 149,675
Deferred income taxes 1,306 (13,956) (1,452)
Gain on sale of debt securities, net 0 0 (1,347)
Amortization of marketable securities purchased at a premium 0 0 578
Non-cash interest expense 2,813 2,469 853
Change in fair value of strategic investments (1,830) (4,823) 0
Changes in operating assets and liabilities, net of impact of acquisitions      
Accounts receivable, net (258,109) (125,354) (73,022)
Deferred contract acquisition costs (298,716) (234,308) (150,975)
Prepaid expenses and other assets (46,807) (29,535) 2,198
Accounts payable (15,463) 33,248 11,325
Accrued expenses and other liabilities 58,923 38,483 33,083
Accrued payroll and benefits 65,226 32,681 33,212
Operating lease liabilities (10,364) (9,900) (8,105)
Deferred revenue 825,751 616,408 338,803
Net cash provided by operating activities 941,007 574,784 356,566
Investing activities      
Purchases of property and equipment (235,019) (112,143) (52,799)
Capitalized internal-use software and website development costs (29,095) (20,866) (10,864)
Purchases of strategic investments (21,808) (16,309) (1,500)
Business acquisitions, net of cash acquired (18,349) (414,518) (85,517)
Purchases of intangible assets (2,323) (680) (180)
Purchases of investments (250,000) 0 (84,904)
Proceeds from sales of investments 0 0 639,586
Purchases of deferred compensation investments (64) 0 0
Maturities of marketable securities 0 0 91,605
Net cash (used in) provided by investing activities (556,658) (564,516) 495,427
Financing activities      
Payments of debt issuance costs related to revolving line of credit 0 (219) (3,328)
Payments of debt issuance costs related to Senior Notes 0 (1,581) 0
Proceeds from issuance of Senior Notes, net of debt financing costs 0 0 739,569
Repayment of loan payable (1,591) 0 0
Proceeds from issuance of common stock upon exercise of stock options 8,655 15,899 28,831
Proceeds from issuance of common stock under the employee stock purchase plan 59,419 50,277 34,263
Capital contributions from non-controlling interest holders 10,954 8,155 800
Net cash provided by financing activities 77,437 72,531 800,135
Effect of foreign exchange rates on cash, cash equivalents and restricted cash (1,495) (4,774) 1,682
Net increase in cash, cash equivalents and restricted cash 460,291 78,025 1,653,810
Cash, cash equivalents and restricted cash at beginning of period 1,996,633 1,918,608 264,798
Cash, cash equivalents and restricted cash at end of period 2,456,924 1,996,633 1,918,608
Cash and cash equivalents 2,455,369 1,996,633 1,918,608
Restricted cash included in prepaid expenses and other assets 1,555 0 0
Total cash, cash equivalents and restricted cash shown in the consolidated statements of cash flows 2,456,924 1,996,633 1,918,608
Supplemental disclosure of cash flow information:      
Interest paid 22,551 13,088 18
Income taxes paid, net of refunds received 11,943 74,677 1,732
Supplemental disclosure of non-cash investing and financing activities:      
Net increase in property and equipment included in accounts payable and accrued expenses 22,421 6,522 1,042
Vesting of early exercised stock options 2,204 3,165 3,318
Equity consideration for acquisitions 50 4,011 3,842
Debt financing costs, accrued but not paid 0 0 1,581
Operating lease liabilities arising from obtaining operating right of-use assets $ 18,464 $ 4,867 $ 6,249